Ovulation: An Inflammatory Cascade of Gene Expression

The Ovary: Second Edition

Volumn , Issue , 2004, Pages 145-165

  Espey, Lawrence L ^a   Bellinger, Adam S ^b   Healy, Jane A ^c  

^a TRINITY UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34249809088     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012444562-8/50010-0     Document Type: Chapter

References (263)

1. Espey L.L. Ovulation. Encyclopedia of Reproduction 1999, Vol. 3:605-614. Academic Press, San Diego. E. Knobil, J.D. Neill (Eds.).
2. Espey L.L., Lipner H. Ovulation. The Physiology of Reproduction 1994, 725-780. Raven Press, New York. E. Knobil, J.D. Neill (Eds.).
3. Espey L.L., Richards J.S. Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat. Biol. Reprod. 2002, 67:1662-1670.
4. Richards J.S., Russell D.L., Ochsner S., Espey L.L. Ovulation: New dimensions and new regulators of the inflammatory-like response. Annu. Rev. Physiol. 2002, 64:69-92.
5. Richards J.S., Russell D.L., Ochsner S., Hsieh M., Doyle K.H., Falender A.E., Lo Y.K., Sharma S.C. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Rec. Prog. Hormone Res. 2002, 57:195-220.
6. Gashler A., Sukhatme V.P. Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acids Res. Mol. Biol. 1995, 50:191-224.
7. Kachigian L.M., Collins T. Early growth response factor 1: A pleiotropic mediator of inducible gene expression. J. Mol. Med. 1998, 76:613-616.
8. Beckmann A.M., Wilce P.A. Egr transcription factors in the nervous system. Neurochem. Int. 1997, 31:477-510.
9. Okada M., Fujita T., Olson K.E., Collins T., Stern D.M., Yan S.F., Pinsky D.J. Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation. FASEB J. 2001, 15:2757-2759.
10. Silverman E.S., DeSanctis G.T., Boyce J., Maclean J.A., Jiao A., Green F.H., Grasemann H., Faunce D., Fitzmaurice G., Shi G.P., Stein-Streilein J., Milbrandt J., Collins T., Drazen J.M. The transcription factor early growth-response factor 1 modulates tumor necrosis factor-α, immunoglobulin E, and airway responsiveness in mice. Am. J. Respir. Crit. Care Med. 2001, 163:778-785.
11. Adashi E.Y. The potential relevance of cytokines to ovarian physiology: The emerging role of resident ovarian cells of the white blood cell series. Endocr. Rev. 1990, 11:454-464.
12. Terranova P.F., Rice V.M. Review: Cytokine involvement in ovarian processes. Am. J. Reprod. Immunol. 1997, 37:50-63.
13. Espey L.L., Ujioka T., Russell D., Skelsey M., Vladu B., Robker R.L., Okamura H., Richards J.S. Induction of early growth response protein 1 gene expression in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Endocrinology 2000, 141:2385-2391.
14. Saliba E., Henrot A. Inflammatory mediators and neonatal brain damage. Biol. Neonate 2001, 79:224-227.
15. Adashi E.Y. The potential role of interleukin-1 in the ovulatory process: An evolving hypothesis. Mol. Cell. Endocrinol. 1998, 140:77-81.
16. Kol S., Kehat I., Adashi E.Y. Ovarian interleukin-1-induced gene expression: Privileged genes threshold theory. Med. Hypotheses 2001, 58:6-8.
17. Chung K.W., Ando M., Adashi E.Y. Periovulatory and interleukin (IL)-1-dependent regulation of IL-6 in the immature rat ovary: A specific IL-1 receptor-mediated eicosanoid-dependent effect. J. Soc. Gynecol. Investig. 2000, 7:301-308.
18. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 2000, 19:19-27.
19. Crofford L.J. COX-1 and COX-2 tissue expression: Implications and predictions. J. Rheumatol. 1997, 49:15-19. (Suppl).
20. Wadleigh D.J., Reddy S.T., Kopp E., Ghosh S., Herschman H.R. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J. Biol. Chem. 2000, 275:6259-6266.
21. Lim H., Paria B.C., Das S.K., Dinchuk J.E., Langenbach R., Trzaskos J.M., Dey S.K. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997, 91:197-208.
22. Wang J.M., Chao J.R., Chen W., Kuo M.L., Yen J.J., Yang-Yen H.F. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3 kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol. Cell. Biol. 1999, 19:6195-6206.
23. Leo C.P., Hsu S.Y., Chun S.Y., Bae H.W., Hsueh A.J. Characterization of the antiapoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1) and the stimulation of its message by gonadotropins in the rat ovary. Endocrinology 1999, 140:5465-5468.
24. Wilson C.L., Safe S. Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol. Pathol. 1998, 26:672-673.
25. Harper P.A., Wong J.Y., Lam M.S., Okey A.B. Polymorphisms in the human AH receptor. Chem. Biol. Interact. 2002, 141:161-187.
26. Durocher F., Morissette J., Simard J. Genetic linkage mapping of the CYP11A1 gene encoding the cholesterol side-chain cleavage P450scc close to the CYP1A1 gene and D15S204 in the chromosome 15q22.33-q23 region. Pharmacogenetics 1998, 8:49-53.
27. Chaffin C.L., Stouffer R.L., Duffy D.M. Gonadotropin and steroid regulation of steroid receptor and aryl hydrocarbon receptor messenger ribonucleic acid in macaque granulosa cells during the periovulatory interval. Endocrinology 1999, 140:4753-4760.
28. Mizuyachi K., Son D.S., Rozman K.K., Terranova P.F. Alteration in ovarian gene expression in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin: Reduction of cyclooxygenase-2 in the blockage of ovulation. Reprod. Toxicol. 2002, 16:299-307.
29. Oh-hama T. Evolutionary consideration on 5-aminolevulinate synthase in nature. Origins Life Evol. Biosph. 1997, 27:405-412.
30. Thunell S. Porphyrins, porphyrin metabolism, and porphyrias. I. Update. Scand. J. Clin. Lab. Invest. 2000, 60:509-540.
31. Suffredini A.F., Fantuzzi G., Badolato R., Oppenheim J.J., O'Grady N.P. New insights into the biology of the acute phase response. J. Clin. Immunol. 1999, 19:203-214.
32. Rosenberg D., Groussin L., Jullian E., Perlemoine K., Bertagna X., Bertherat J. Role of the PKA-regulated transcription factor CRB in development and tumorigenesis of endocrine tissues. Ann. N. Y. Acad. Sci. 2002, 968:65-74.
33. Quinn P.G. Mechanisms of basal and kinase-inducible transcription activation by CREB. Prog. Nucleic Acid Res. Mol. Biol. 2002, 72:269-305.
34. Don J., Stelzer G. The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis. Mol. Cell. Endocrinol. 2002, 187:115-124.
35. Servillo G., Della Fazia M.A., Sassone-Corsi P. Coupling cAMP signaling to transcription in the liver: Pivotal role of CREB and CREM. Exp. Cell. Res. 2002, 275:143-154.
36. Benyo D.F., Zeleznik A.J. Cyclic adenosine monophosphate signaling in the primate corpus luteum: Maintenance of protein kinase A activity throughout the luteal phase of the menstrual cycle. Endocrinology 1997, 138:3452-3458.
37. Somers J.P., DeLoia J.A., Zeleznik A.J. Adenovirus-directed expression of a nonphosphorylatable mutant of CREB (cAMP response element-binding protein) adversely affects the survival, but not the differentiation, of rat granulosa cells. Mol. Endocrinol. 1999, 13:1364-1372.
38. Mukherjee A., Urban J., Sassone-Corsi P., Mayo K.E. Gonadotropins regulate inducible cyclic adenosine 3'5'-monophosphate early repressor in the rat ovary: Implications for inhibit-α subunit gene expression. Mol. Endocrinol. 1998, 12:785-800.
39. Stylianou E., Saklatvala J. Interleukin-1. Int. J. Biochem. Cell. Biol. 1998, 30:1075-1079.
40. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001, 11:372-377.
41. Matt T. Transcriptional control of the inflammatory response: A role for the CREB-binding protein (CBP). Acta Med. Austriaca 2002, 29:77-79.
42. Niswender G.D. Molecular control of luteal secretion of progesterone. Reproduction 2002, 123:333-339.
43. Herrmann M., Scholmerich J., Straub R.H. Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro: A short tabular data collection. Ann. N. Y. Acad. Sci. 2002, 996:166-168.
44. Hum D.W., Miller W.L. Transcriptional regulation of human genes for steroidogenic enzymes. Clin. Chem. 1993, 39:333-340.
45. Kaynard A.H., Periman L.M., Simard J., Melner M.H. Ovarian 3β-hydroxysteroid dehydrogenase and sulfated glycoprotein-2 gene expression are differentially regulated by the induction of ovulation, pseudopregnancy, and luteolysis in the immature rat. Endocrinology 1992, 130:2192-2200.
46. Boerboom D., Sirois J. Equine P450 cholesterol side-chain cleavage and 3β-hydroxysteroid dehydrogenase/δ(5)-δ(4) isomerase molecular cloning and regulation of their messenger ribonucleic acids in equine follicles during the ovulatory process. Biol. Reprod. 2001, 64:206-215.
47. Chaffin C.L., Dissen G.A., Stouffer R.L. Hormonal regulation of steroidogenic enzyme expression granulosa cells during the periovulatory interval in monkeys. Mol. Hum. Reprod. 2000, 6:11-18.
48. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annu. Rev. Physiol. 2001, 63:193-213.
49. Ronen-Fuhrmann T., Timberg R., King S.R., Hales K.H., Hales D.B., Stocco D.M., Orly J. Spatio-temporal expression patterns of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary. Endocrinology 1998, 139:303-315.
50. Kerban A., Boerboom D., Sirois J. Human chorionic gonadotropin induces an inverse regulation of steroidogenic acute regulatory protein messenger ribonucleic acid in theca interna and granulosa cells of equine preovulatory follicles. Endocrinology 1999, 140:667-674.
51. Grinberg A.V., Hannemann F., Schiffler B., Muller J., Heinemann U., Bernharddt R. Adrenodoxin: Structure, stability, and electron transfer properties. Proteins 2000, 40:590-612.
52. 2-adrenergic receptor: Regulation of adrenodoxin and steroidogenic acute regulatory protein by adrenergic agents. Mol. Cell. Endocrinol. 2000, 168:53-63.
53. Natraj U., Richards J.S. Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology 1993, 133:761-769.
54. Robker R.L., Russell D.L., Espey L.L., Lydon J.P., O'Malley B.W., Richards J.S. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc. Natl. Acad. Sci. USA 2000, 97:4689-4694.
55. Snyder B.W., Beecham G.D., Schane H.P. Inhibition of ovulation in rats with epostane, an inhibitor of 3β-hydroxysteroid dehydrogenase. Proc. Soc. Exp. Biol. Med. 1984, 176:238-242.
56. 2α during ovulation in the gonadotropin-primed immature rat. Endocrinology 1990, 127:259-263.
57. Espey L.L., Yoshioka S., Russell D.L., Robker R.L., Fujii S., Richards J.S. Ovarian expression of a disintegrin and metalloproteinase with thrombospondin motifs during ovulation in the gonadotropin-primed immature rat. Biol. Reprod. 2000, 62:1090-1095.
58. Espey L.L., Tanaka N., Adams R.F., Okamura H. Ovarian hydroxyeicosatetraenoic acids compared to prostanoids and steroids during ovulation in the rat. Am. J. Physiol. 1991, 260:E163-E169.
59. Espey L.L. Ovulation as an inflammatory reaction-A hypothesis. Biol. Reprod. 1980, 22:73-106.
60. Espey L.L. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol. Reprod. 1994, 50:233-238.
61. Chen G., Goeddel D.V. TNF-R1 signaling: A beautiful pathway. Science 2002, 296:1634-1635.
62. Ando M., Kol S., Kokia E., Ruutiainen-Altman K., Sirois J., Rohan R.M., Payne D.W., Adashi E.Y. Rat ovarian prostaglandin endoperoxide synthase-1 and -2: Periovulatory expression of granulosa cell-based interleukin-1-dependent enzymes. Endocrinology 1998, 139:2501-2508.
63. Kol S., Ruutiainen-Altman K., Scherzer W.J., Ben-Shlomo I., Ando M., Rohan R.M., Adashi E.Y. The rat intraovarian interleukin (IL)-1 system: Cellular localization, cyclic variation, and hormonal regulation of IL-1β and of the type I and type II IL-1 receptors. Mol. Cell. Endocrinol. 1999, 149:115-128.
64. Levitas E., Chamoun D., Udoff L.C., Ando M., Resnick C.E., Adashi E.Y. Periovulatory and interleukin-1β-dependent up-regulation of intraovarian vascular endothelial growth factor (VEGF) in the rat: Potential role for VEGF in the promotion of periovulatory angiogenesis and vascular permeability. J. Soc. Gynecol. Investig. 2000, 7:51-60.
65. Chen Y.J., Feng Q., Liu Y.X. Expression of the steroidogenic acute regulatory protein and luteinizing hormone receptor and their regulation by tumor necrosis factor alpha in rat corpora lutea. Biol. Reprod. 1999, 60:419-427.
66. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 1998, 273:29279-29282.
67. Sirois J., Richards J.S. Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Evidence for the role of a cis-acting C/EBPβ promoter element. J. Biol. Chem. 1993, 268:21931-21938.
68. Piontkewitz Y., Enerback S., Hedin L. Expression of CCAAT enhancer binding protein-α (C/EBPα) in the rat ovary: Implications for follicular development and ovulation. Dev. Biol. 1996, 179:288-296.
69. Pall M., Hellberg P., Brännström M., Mikuni M., Peterson C.M., Sundfeldt K., Norden B., Hedin L., Enerback S. The transcription factor C/EBP-β and its role in ovarian function: Evidence for direct involvement in the ovulatory process. EMBO J. 1997, 16:5273-5279.
70. Sahnoun Z., Jamoussi K., Zeghal K.M. Free radicals and antioxidants: Physiology, human pathology, and therapeutic aspects (part II). Therapie 1998, 53:315-339.
71. Suzuki H., Mori M., Seto K., Shibata F., Nagahashi S., Kawaguchi C., Suzuki M., Matsui H., Watanabe K., Miura S., Ishii H. Rat CXC chemokine GRO/CINC-1 paradoxically stimulate the growth of gastric epithelial cells. Aliment. Pharmacol. Ther. 2000, 14(Suppl 1):94-100.
72. Shibata F. The role of rat cytokine-induced neutrophil chemoattractants (CINCs) in inflammation. Yakugaku Zasshi 2002, 122:263-268.
73. Ushigoee K., Irahara M., Fukumochi M., Kamada M., Aono T. Production and regulation of cytokine-induced neutrophil chemoattractant in rat ovulation. Biol. Reprod. 2000, 63:121-126.
74. Oral E., Seli E., Bahtiyar M.O., Jones E.E., and Arici A. Growth-regulated-α expression in human preovulatory follicles and ovarian cells. Am. J. Reprod. Immunol. 38, 19-25.
75. Karstrom-Encrantz L., Runesson E., Bostrom E.K., Brännström M. Selective presence of the chemokine growth-regulated oncogene-α (GRO-α) in the human follicle and secretion from cultured granulosa-lutein cells at ovulation. Mol. Hum. Reprod. 1998, 4:1077-1083.
76. Irahara M., Yasui T., Tezuka M., Ushigoe K., Yamano S., Kamada M., Aono T. Evidence that Toki-Shakuyaku-san and its ingredients enhance the secretion of a cytokine-induced neutrophil chemoattractant (CINC/gro) in the ovulatory process. Methods Find. Exp. Clin. Pharmacol. 2000, 22:725-730.
77. Yan S.F., Fujita T., Lu J., Okada K., Shan Zou Y., Mackman N., Pinsky D.J., Stern D.M. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat. Med. 2000, 6:1355-1361.
78. Micera A., Vigneti E., Pickholtz D., Reich R., Pappo O., Bonini S., Maquart F.X., Aloe L., Levi-Schaffer F. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc. Natl. Acad. Sci. USA 2001, 98:6162-6167.
79. Barouch R., Kazimirsky G., Appel E., Brodie C. Nerve growth factor regulates TNF-α production in mouse macrophages via MAP kinase activation. J. Leukoc. Biol. 2001, 69:1019-1026.
80. Dissen G.A., Hill D.F., Costa M.E., Les Dees C.W., Lara H.E., Ojeda S.R. Endocrinology 1996, 137:198-209.
81. Dissen G.A., Parrott J.A., Skinner M.K., Hill D.F., Costa M.E., Ojeda S.R. Direct effects of nerve growth factor on thecal cells from antral ovarian follicles. Endocrinology 2000, 141:4736-4750.
82. Dvorak H.F., Nagy J.A., Feng D., Brown L.F., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 1999, 237:97-132.
83. van Hinsbergh V.W., Collen A., Koolwijk P. Role of fibrin matrix in angiogenesis. Ann. N. Y. Acad. Sci. 2001, 936:426-437.
84. Thurston G. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J. Anat. 2002, 200:575-580.
85. Garrido C., Saule S., Gospodarowicz D. Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors 1993, 8:109-117.
86. Koos R.D. Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: Potential roles in follicular rupture. Biol. Reprod. 1995, 52:1426-1435.
87. Mastorakos G., Webster E.L., Friedman T.C., Chrousos G.P. Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary. J. Clin. Invest. 1993, 92:961-968.
88. Schafer M., Mousa S.A., Stein C. Corticotropin-releasing factor in antinociception and inflammation. Eur. J. Pharmacol. 1997, 323:1-10.
89. Baigent S.M. Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 2001, 22:809-820.
90. Nappi R.E., Rivest S. Stress-induced genetic expression of a selective corticotropin-releasing factor-receptor subtype within the rat ovaries, an effect dependent on the ovulatory cycle. Biol. Reprod. 1995, 53:1417-1428.
91. Turini M.E., DuBois R.N. Cyclooxygenase-2: A therapeutic target. Annu. Rev. Med. 2002, 53:35-57.
92. Shirakata Y., Komurasaki T., Toyoda H., Hanakawa Y., Yamasaki K., Tokumaru S., Sayama K., Hashimoto K. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J. Biol. Chem. 2000, 275:5748-5753.
93. Robert C., Gagne D., Bousquet D., Barnes F.L., Sirard M.A. Differential display and suppressive subtractive hybridization used to identify granulosa cell messenger RNA associated with bovine oocyte developmental competence. Biol. Reprod. 2001, 64:1812-1820.
94. Li X., Massa P.E., Hanidu A., Peet G.W., Aro P., Savitt A., Mische S., Li J., Marcu K.B. IKKα, IKKβ, and NEMO/IKKγ are each required for the NF-κB-mediated inflammatory response program. J. Biol. Chem. 2002, 227:45129-45140.
95. Sasaki E., Pai R., Halter F., Komurasaki T., Arakawa T., Kobayashi K., Kuroki T., Tarnawski A.S. Induction of cyclooxygenase-2 in a rat gastric epithelial cell line by epiregulin and basic fibroblast growth factor. J. Clin. Gastroenterol. 1998, 27(Suppl 1):S21-S27.
96. Nathan C. Points of control in inflammation. Nature 2002, 420:846-852.
97. Lawrence T., Willoughby D.A., Gilroy D.W. Anti-inflammatory lipid mediator and insights into the resolution of inflammation. Nat. Rev. Immunol. 2002, 2:787-795.
98. Jung Y., Isaacs J.S., Lee S., Trepel J., Liu Z.G., Neckers L. Hypoxia-inducible factor induction by tumor necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa beta activation. Biochem. J. 2003, 370:1011-1017. 2003.
99. Kupfner J.G., Arcaroli J.J., Yum H.K., Nadler S.G., Yang K.Y., Abraham E. Role of NF-κB in endotoxemia-induced alterations of lung neutrophil apoptosis. J. Immunol. 2001, 167:7044-7051.
100. Taylor C.C., Limback D., Terranova P.F. Src tyrosine kinase activity in rat thecal-interstitial cells and mouse TM3 Leydig cells is positively associated with cAMP-specific phosphodiesterase activity. Mol. Cell. Endocrinol. 1997, 126:91-100.
101. Burnouf C., Pruniaux M.P. Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs. Curr. Pharm. Des. 2002, 8:1255-1296.
102. Combes P., Dickenson J.M. Inhibition of NF-κB-mediated gene transcription by human A2B adenosine receptor in Chinese hamster ovary cells. J. Pharm. Pharmacol. 2001, 53:1153-1156.
103. Kasyapa C.S., Stentz C.L., Davey M.P., Carr D.W. Regulation of IL-15-stimulated TNF-α production by rolipram. J. Immunol. 1999, 163:2836-2843.
104. Jin S.L., Conti M. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses. Proc. Natl. Acad. Sci. USA 2002, 99:7628-7633.
105. Jin S.L., Richard F.J., Kuo W.P., D'Ercole A.J., Conti M. Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc. Natl. Acad. Sci. USA 1999, 96:11998-12003.
106. Fiorentino L., Stehlik C., Oliveira V., Ariza M.E., Godzik A., Reed J.C. A novel PAAD-containing protein that modulates NF-κB induction by cytokines tumor necrosis factor-α and interleukin-1β. J. Biol. Chem. 2002, 277:35333-35340.
107. White R., Leonardsson G., Rosewell I., Ann Jacobs M., Milligan S., Parker M. The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat. Med. 2000, 6:1368-1374.
108. Leonardsson G., Jacobs M.A., White R., Jeffery R., Poulsom R., Milligan S., Parker M. Embryo transfer experiments and ovarian transplantation identify the ovary as the only site in which nuclear receptor interacting protein 1/RIP140 action is crucial for female fertility. Endocrinology 2002, 143:700-707.
109. Abramson S.B., Amin A.R., Clancy R.M., Attur M. The role of nitric oxide in tissue destruction. Best Pract. Res. Clin. Rheumatol. 2001, 15:831-845.
110. Coleman J.W. Nitric oxide: A regulator of mast cell activation and mast cell mediated inflammation. Clin. Exp. Immunol. 2002, 129:4-10.
111. Blantz R.C., Munger K. Role of nitric oxide in inflammatory conditions. Nephron 2002, 90:373-378.
112. Yamagata Y., Nakamura Y., Sugino N., Harada A., Takayama H., Kashida S., Kato H. Alterations in nitrate/nitrite and nitric oxide synthase in preovulatory follicles in gonadotropin-primed immature rats. Endocr. J. 2002, 49:219-226.
113. Srivastava V., Jones B.J., Dookwah H., Hiney J.K., Dees W.L. Ovarian nitric oxide synthase (NOS) gene expression during peripubertal development. Life Sci. 1997, 61:1507-1516.
114. Jablonka-Shariff A., Olson L.M. Hormonal regulation of nitric oxide synthases and their cell-specific expression during follicular development in the rat ovary. Endocrinology 1997, 138:460-468.
115. Nakamura Y., Kashida S., Nakata M., Takiguchi S., Yamagata Y., Takayama H., Sugino N., Kato H. Changes in nitric oxide synthase activity in the ovary of gonadotropin treated rats: the role of nitric oxide during ovulation. Endocr. J. 1999, 46:529-538.
116. Kuno K., Kanada N., Nakashima E., Fujiki F., Ichimura F., Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J. Biol. Chem. 1997, 272:556-562.
117. Tang B.L. ADAMTS: a novel family of extracellular matrix proteases. Int. J. Biochem. Cell Biol. 2001, 33:33-44.
118. Thai S.N., Iruela-Arispe M.L. Expression of ADAMTS1 during murine development. Mech. Dev. 2002, 115:181-185.
119. Sugiura T. Baculoviral expression of correctly processed ADAMTS proteins fused with the human IgG-Fc region. J. Biotechnol. 2003, 100:193-201.
120. Rodriguez-Manzaneque J.C., Westling J., Thai S.N., Luque A., Knauper V., Murphy G., Sandy J.D., Iruela-Arispe M.L. ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem. Biophys. Res. Commun. 2002, 293:501-508.
121. Dong Z., Katar M., Linebaugh B.E., Sloane B.F., Berk R.S. Expression of cathepsins B, D, and L in mouse corneas infected with Pseudomonas aeruginosa. Eur. J. Biochem. 2001, 268:6408-6416.
122. Fiebiger E., Maehhr R., Villadangos J., Weber E., Erickson A., Bikoff E., Ploegh H.L., Lennon-Dumenil A.M. Invariant chain controls the activity of extracellular cathepsin L. J. Exp. Med. 2002, 196:1263-1269.
123. Robker R.L., Russell D.L., Yoshioka S., Sharma C., Lydon J.P., O'Malley B.W., Espey L.L., Richards J.S. Ovulation: A multigene, multistep process. Steroids 2000, 65:559-570.
124. Cuzner M.L., Opdenakker G. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 1999, 94:1-14.
125. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr. Protein Pept. Sci. 2002, 3:409-421.
126. Curry T.E., Mann J.S., Huang M.H., Keeble S.C. Gelatinase and proteoglycanase activity during the periovulatory period in the rat. Biol. Reprod. 1992, 46:256-264.
127. Curr T.E., Osteen K.G. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol. Reprod. 2001, 64:1285-1296.
128. Balbin M., Fueyo A., Lopez J.M., Diez-Itza I., Velasco G., Lopez-Otin C. Expression of collagenase-3 in the rat ovary during the ovulatory process. J. Endocrinol. 1996, 149:405-415.
129. Bagavandoss P. Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary. J. Endocrinol. 1998, 158:221-228.
130. Curry T.E., Song L., Wheeler S.E. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Biol. Reprod. 2001, 65:855-865.
131. Hagglund A.C., Ny A., Leonardsson G., Ny T. Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation. Endocrinology 1999, 140:4351-4358.
132. Beers W.H. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell 1975, 6:379-386.
133. Shimada H., Mori T., Takada A., Takada Y., Noda Y., Takai I., Kohda H., Nishimura T. Use of chromogenic substrate S-2251 for determination of plasminogen activator in rat ovaries. Thromb. Haemost. 1981, 46:507-510.
134. Shen X., Minoura H., Yoshida T., Toyoda N. Changes in ovarian expression of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 messenger ribonucleic acids during ovulation in rat. Endocr. J. 1997, 44:341-348.
135. Leonardsson G., Peng X.R., Liu K., Nordstrom L., Carmeliet P., Mulligan R., Collen D., Ny T. Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: Functional redundancy among physiological plasminogen activator. Proc. Natl. Acad. Sci. USA 1995, 92:12446-12450.
136. Ny A., Nordstrom L., Carmeliet P., Ny T. Studies of mice lacking plasminogen activator gene function suggest that plasmin production prior to ovulation exceeds the amount needed for optimal ovulation efficiency. Eur. J. Biochem. 1997, 244:487-493.
137. Ny A., Leonardsson G., Hagglund A.C., Hagglof P., Ploplis V.A., Carmeliet P., Ny T. Ovulation in plasminogen-deficient mice. Endocrinology 1999, 140:5030-5035.
138. Valent P., Schernthaner G.H., Sperr W.R., Fritsch G., Agis H., Willheim M., Buhring H.J., Orfao A., Escribano L. Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol. Rev. 2001, 179:74-81.
139. Zhang H., Downey G.P., Suter P.M., Slutsky A.S., Ranieri V.M. Conventional mechanical ventilation is associated with bronchoalveolar lavage-induced activation of polymorphonuclear leukocytes: A possible mechanism to explain the systemic consequences of ventilator-induced lung injury in patients with ARDS. Anesthesiology 2002, 97:1426-1433.
140. Dijkstra G., Zandvoort A.J., Kobold A.C., de Jager-Krikken A., Heeringa P., van Goor H., van Dullemen H.M., Tervaert J.W., van de Loosdrecht A., Moshage H., Jansen P.L. Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel disease. Scand. J. Gastroenterol. 2002, 37:546-554.
141. Vischer U.M., Wagner D.D. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 1993, 82:1184-1191.
142. Harrigan M.T., Campbell N.F., Bourgeois S. Identification of a gene induced by glucocorticoids in murine T-cells: A potential G protein-coupled receptor. Mol. Endocrinol. 1991, 5:1331-1338.
143. Kotani M., Detheux M., Vandenbogaerde A., Communi D., Vanderwinden J.M., Le Poul E., Brezillon S., Tyldesley R., Suarez-Huerta N., Vandeput F., Blanpain C., Schiffmann S.N., Vassart G., Parmentier M. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J. Biol. Chem. 2001, 276:34631-34636.
144. Wang D., Herman J.P., Pritchard L.M., Spitzer R.H., Ahlbrand R.L., Kramer G.L., Petty F., Sallee F.R., Richtand N.M. Cloning, expression, and regulation of a glucocorticoid-induced receptor in rat brain: Effect of repetitive amphetamine. J. Neurosci. 2001, 21:9027-9035.
145. Communi D., Gonzalez N.S., Detheux M., Brezillon S., Lannoy V., Parmentier M., Boeynaems J.M. Identification of a novel human ADP receptor coupled to G(i). J. Biol. Chem. 2001, 276:41479-41485.
146. Brezillon S., Detheux M., Parmentier M., Hokfelt T., Hurd Y.L. Distribution of an orphan G-protein coupled receptor (JP05) mRNA in the human brain. Brain Res. 2001, 921:21-30.
147. Lee D.K., Nguyen T., O'Neill G.P., Cheng R., Liu Y., Howard A.D., Coulombe N., Tan C.P., Tang-Nguyen A.T., George S.R., O'Dowd B.F. Discovery of a receptor related to the galanin receptors. FEBS Lett. 1999, 446:103-107.
148. Katsumata N., Chakraborty C., Myal Y., Schroedter I.C., Murphy L.J., Shiu R.P., Friesen H.G. Molecular cloning and expression of peptide 23, a growth hormone releasing hormone-inducible pituitary protein. Endocrinology 1995, 136:1332-1339.
149. Chakraborty C., Katsumata N., Myal Y., Schroedter I.C., Brazeau P., Murphy L.J., Shiu R.P., Friesen H.G. Age-related changes in peptide-23/pancreatitis-associated protein and pancreatic stone protein/reg gene expression in the rat and regulation by growth hormone-releasing hormone. Endocrinology 1995, 136:1843-1849.
150. Heller A., Fiedler F., Schmeck J., Luck V., Iovanna J., Koch T. Pancreatitis-associated protein protects the lung from leukocyte-induced injury. Anesthesiology 1999, 91:1408-1414.
151. Yoshioka S., Fujii S., Richards J.S., Espey L.L. Gonadotropin-induced expression of pancreatitis-associated protein-III mRNA in the rat ovary at the time of ovulation. J. Endocrinol. 2002, 174:485-492.
152. Mitchell R.A., Bucala R. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin. Cancer Biol. 2000, 10:359-366.
153. Wada S., Kudo T., Kudo M., Sakuragi N., Hareyama H., Nishihira J., Fujimoto S. Induction of macrophage migration inhibitory factor in human ovary by human chorionic gonadotrophin. Hum. Reprod. 1999, 14:395-399.
154. Watanabe R., Fujii H., Yamamoto A., Yamaguchi H., Takenouchi T., Kameda K., Ito M., Ono T. Expression of cutaneous fatty acid-binding protein and its mRNA in rat skin. Arch. Dermatol. Res. 1996, 289:184.
155. Jing C., Beesley C., Foster C.S., Rudland P.S., Fujii H., Ono T., Chen H., Smith P.H., Ke Y. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer. Cancer Res. 2000, 60:2390-2398.
156. Jing C., Beesley C., Foster C.S., Chen H., Rudland P.S., West D.C., Fujii H., Smith P.H., Ke Y. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res. 2001, 61:4357-4364.
157. Leo C.P., Pisarska M.D., Hsueh A.J. DNA array analysis of changes in preovulatory gene expression in the rat ovary. Biol. Reprod. 2001, 65:269-276.
158. Nakagawa T., Kaneko M., Inamura S., Satoh M. Intracerebroventricular administration of nocistatin reduces inflammatory hyperalgesia in rats. Neurosci. Lett. 1999, 265:64-66.
159. Itoh M., Takasaki I., Andoh T., Nojima H., Tominaga M., Kuraishi Y. Induction by carrageenan inflammation of prepronociceptin mRNA in VR1-immunoreactive neurons in rat dorsal root ganglia. Neurosci. Res. 2001, 40:227-233.
160. Zaveri N.T., Green C.J., Polgar W.E., Huynh N., Toll L. Regulation of transcription of the human prepronociceptin gene by Sp1. Gene 2002, 290:45-52.
161. Zaveri N.T., Green C.J., Toll L. Transcriptional regulation of the human prepronociceptin gene. Biochem. Biophys. Res. Commun. 2000, 276:710-717.
162. Xie G.X., Ito E., Maruyama K., Suzuki Y., Sugano S., Sharma M., Pietruck C., Palmer P.P. The promoter region of human prepro-nociceptin gene and its regulation by cyclic AMP and steroid hormones. Gene 1999, 238:427-436.
163. Okuda-Ashitaka E., Ito S. Nocistatin: A novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor. Peptides 2000, 21:1101-1109.
164. Berman D.M., Gilman A.G., Mammalian RGS proteins: Barbarians at the gate. J. Biol. Chem. 273, 1269-1272.
165. Hepler J.R. Emerging roles for RGS proteins in cell signaling. Trends Pharmacol. Sci. 1999, 20:376-382.
166. Ujioka T., Russell D.L., Okamura H., Richards J.S., Espey L.L. Expression of regulatory of G-protein signaling protein-2 gene in the rat ovary at the time of ovulation. Biol. Reprod. 2000, 63:1513-1517.
167. Ganea D., Delgado M. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity. Crit. Rev. Oral Biol. Med. 2002, 13:229-237.
168. Martinez C., Abad C., Delgado M., Arranz A., Juarranz M.G., Rodriguez-Hench N., Brabet P., Leceta J., Gomariz R.P. Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor. Proc. Natl. Acad. Sci. USA 2002, 99:1053-1058.
169. Ko C., In Y.H., Park-Sarge O.K. Role of progesterone receptor activation in pituitary adenylate cyclase-activating polypeptide gene expression in rat ovary. Endocrinology 1999, 140:5185-5194.
170. Koh P.O., Kwak S.D., Kang S.S., Cho G.J., Chun S.Y., Kwon H.B., Choi W.S. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type I A receptor mRNAs in granulosa cells of preovulatory follicles of the rat ovary. Mol. Reprod. Dev. 2000, 55:379-386.
171. Park J.I., Kim W.J., Wang L., Park H.J., Lee J., Park J.H., Kwon H.B., Tsafriri A., Chun S.Y. Involvement of progesterone in gonadotrophin-induced pituitary adenylate cyclase-activating polypeptide gene expression in pre-ovulatory follicles of rat ovary. Mol. Hum. Reprod. 2000, 6:238-245.
172. Apa R., Lanzone A., Miceli F., Vaccari S., Macchione E., Stefanini M., Canipari R. Pituitary adenylate cyclase-activating polypeptide modulates plasminogen activator expression in rat granulosa cell. Biol. Reprod. 2002, 66:830-835.
173. Reynolds J.J. Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Dis. 1996, 2:70-76.
174. Opdenakker G., Van den Steen P.E., Dubois B., Nelissen I., Van Coillie E., Masure S., Proost P., Van Damme J. Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 2001, 69:851-859.
175. Simpson K.S., Byers M.J., Curry T.E. Spatiotemporal messenger ribonucleic acid expression of ovarian tissue inhibitors of metalloproteinases throughout the rat estrous cycle. Endocrinology 2001, 142:2058-2069.
176. Komar C.M., Matousek M., Mitsube K., Mikuni M., Brännström M., Curry T.E. Effects of genistein on the periovulatory expression of messenger ribonucleic acid for matrix metalloproteinases and tissue inhibitors of metalloproteinases in the rat ovary. Reproduction 2001, 121:259-265.
177. Simpson K.S., Komar C.M., Curry T.E. Localization and expression of tissue inhibitor of metallo-proteinase-4 in the immature gonadotropin-stimulated and adult rat ovary. Biol. Reprod. 2003, 68:214-221.
178. Espey L.L., Ujioka T., Okamura H., Richards J.S. Metallothionein-1 messenger RNA transcription in steroid-secreting cells of the rat ovary during the periovulatory period. Biol. Reprod. 2003, 68:1895-1902.
179. Curry T.E., Wheeler S.E. Cellular localization of tissue inhibitors of metalloproteinase in the rat ovary throughout pseudopregnancy. Biol. Reprod. 2002, 67:1943-1951.
180. Gaddy-Kurten D., Hickey G.J., Fey G.H., Gauldie J., Richards J.S. Hormonal regulation and tissue-specific localization of α2-macroglobulin in rat ovarian follicles and corpora lutea. Endocrinoloogy 1989, 125:2985-2995.
181. Bardos T., Kamath R.V., Mikecz K., Glant T.T. Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-α-stimulated gene-6) in murine models of experimental arthritis. Am. J. Pathol. 2001, 159:1711-1721.
182. Glant T.T., Kamath R.V., Bardos T., Gal I., Szanto S., Murad Y.M., Sandy J.D., Mort J.S., Roughley P.J., Mikecz K. Cartilage-specific constitutive expression of TSG-6 protein (product of tumor necrosis factor α-stimulated gene 6) provides a chondroprotective, but not anti-inflammatory, effect in antigen-induced arthritis. Arthritis Rheum. 2002, 46:2207-2218.
183. Yoshioka S., Ochsner S., Russell D.L., Ujioka T., Fujii S., Richards J.S., Espey L.L. Expression of tumor necrosis factor-stimulated gene-6 in the rat ovary in response to an ovulatory dose of gonadotropin. Endocrinology 2000, 141:4114-4119.
184. Carrette O., Nemade R.V., Day A.J., Brickner A., Larsen W.J. TSG-6 is concentrated in the extracellular matrix of mouse cumulus oocyte complexes through hyaluronan and inter-α-inhibitor binding. Biol. Reprod. 2001, 65:301-308.
185. Mbebi C., Hantai D., Jandrot-Perrus M., Doyennette M.A., Verdiere-Sahuque M. Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors. J. Cell Physiol. 1999, 179:305-314.
186. Wiedermann C.J., Roemisch J. The anti-inflammatory actions of antithrombin-a review. Acta Med. Austriaca 2002, 29:89-92.
187. Opal S.M., Kessler C.M., Roemisch J., Knaub S. Antithrombin, heparin, and heparan sulfate. Crit. Care Med. 2002, 30(Suppl 5):S325-S331.
188. Hasan S., Hosseini G., Princivalle M., Dong J.C., Birsan D., Cagide C., de Agostini A.I. Coordinate expression of anticoagulant heparan sulfate proteoglycans and serine protease inhibitors in the rat ovary: A potent system of proteolysis control. Biol. Reprod. 2002, 66:144-158.
189. Hagglund A.C., Ny A., Liu K., Ny T. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation. Endocrinology 1996, 137:5671-5677.
190. Kasza A., Kowanetz M., Poslednik K., Witek B., Kordula T., Koj A. Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells. Cytokine 2001, 16:187-190.
191. Nicosia M., Moger W.H., Dyer C.A., Prack M.M., Williams D.L. Apolipoprotein-E messenger RNA in rat ovary is expressed in theca and interstitial cells and presumptive macrophage, but not in granulosa cells. Mol. Endocrinol. 1992, 6:978-988.
192. Larkin L., Khachigian L.M., Jessup W. Regulation of apolipoprotein E production in macrophages (review). Int. J. Mol. Med. 2000, 6:253-258.
193. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., Guo L., Van Eldik L.J. Apolipoprotein E and apolipoprotein E receptors modulate A β-induced glial neuroinflammatory responses. Neurochem. Int. 2001, 39:427-434.
194. Curtiss L.K., Boisvert W.A. Apolipoprotein E and atherosclerosis. Curr. Opin. Lipidol. 2000, 11:243-251.
195. Riddell D.R., Owen J.S. Nitric oxide and platelet aggregation. Vitam. Horm. 1999, 57:25-48.
196. Polacek D., Beckmann M.W., Schreiber J.R. Rat ovarian apolipoprotein E: Localization and gonadotropic control of messenger RNA. Biol. Reprod. 1992, 46:65-72.
197. Yodoi J., Nakamura H., Masutani H. Redox regulation of stress signals: Possible roles of dendritic stellate TRX producer cells (DST cell types). Biol. Chem. 2002, 383:585-590.
198. Fitzpatrick F.A. Inflammation, carcinogenesis, and cancer. Int. Immunopharmacol. 2001, 1:1651-1667.
199. Yaron Y., Schwartz D., Evans M.I., Aloni R., Kapon A., Rotter V. P53 tumor suppressor gene expression in the mouse ovary during an artificially induced ovulatory cycle. J. Reprod. Med. 1999, 44:107-114.
200. Bonder C.S., Dickensheets H.L., Finlay-Jones J.J., Donnelly R.P., Hart P.H. Involvement of the IL-2 receptor γ-chain (γc) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production. J. Immunol. 1998, 160:4048-4056.
201. Mozo L., Gayo A., Suarez A., Rivas D., Zamorano J., Gutierrez C. Glucocorticoids inhibit IL-4 and mitogen-induced IL-4Rα chain expression by different posttranscriptional mechanisms. J. Allergy Clin. Immunol. 1998, 102:968-976.
202. Hart P.H., Bonder C.S., Balogh J., Dickensheet H.L., Donnelly R.P., Finlay-Jones J.J. Differential responses of human monocytes and macrophages to IL-4 and IL-13. J. Leukoc. Biol. 1999, 66:575-578.
203. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Canonica G.W., Jasmin C., Azzarone B. Interleukin (IL)-4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 1998, 101:2129-2139.
204. Coyle P., Philcox J.C., Carey L.C., Rofe A.M. Metallothionein: The multipurpose protein. Cell. Mol. Life Sci. 2002, 59:627-647.
205. Miles A.T., Hawksworth G.M., Beattie J.H., Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol. 2000, 35:35-70.
206. Holmes-McNary M. Nuclear factor κB signaling in catabolic disorders. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5:255-263.
207. Davies K.J. Oxidative stress: The paradox of aerobic life. Biochem. Soc. Symp. 1995, 61:1-31.
208. Mills P.C., Higgins A.J. Oxidant injury, nitric oxide, and pulmonary vascular function: Implications for the exercising horse. Vet. J. 1997, 153:125-148.
209. Li C., Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell. Physiol. 2002, 282:C227-C241.
210. Melov S. Animal models of oxidative stress, aging, and therapeutic antioxidant interventions. Int. J. Biochem. Cell. Biol. 2002, 34:1395-1400.
211. Bautista A.P. Free radicals, chemokines, and cell injury in HIV-1 and SIV infections and alcoholic hepatitis. Free Radic. Biol. Med. 2001, 31:1527-1532.
212. Laroux F.S., Pavlick K.P., Hines I.N., Kawachi S., Harada H., Bharwani S., Hoffman J.M., Grisham M.B. Role of nitric oxide in inflammation. Acta Physiol. Scand. 2001, 173:113-118.
213. Rahman I. Inflammation and the regulation of glutathione level in lung epithelial cells. Antioxid. Redox Signal 1999, 1:425-447.
214. Soltaninassab S.R., Sekhar K.R., Meredity M.J., Freeman M.L. Multifaceted regulation of γ-glutamylcysteine synthetase. J. Cell Physiol. 2000, 182:163-170.
215. Wild A.C., Mulcahy R.T. Regulation of γ-glutamylcysteine synthetase subunit gene expression: Insights into transcriptional control of antioxidant defenses. Free Radic. Res. 2000, 31:281-301.
216. Anderson M.E. Glutathione: An overview of biosynthesis and modulation. Chem. Biol. Interact. 1998, 111-112:1-14.
217. Rahman I., MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur. Respir. J. 2000, 16:534-554.
218. Griffith O.W. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med. 1999, 27:922-935.
219. Clague N., Sevcik M., Stuart G., Brännström M., Janson P.O., Jarrell J.F. The effect of estrous cycle and buthionine sulfoximine on glutathione release from the in vitro perfused rat ovary. Reprod. Toxicol. 1992, 6:533-539.
220. Jarrell J.F., Sevcik M., Stuart G. Regulation of total ovarian glutathione content in the rat. Reprod. Toxicol. 1992, 6:133-135.
221. Hayes J.D., Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000, 61:154-166.
222. Rahman Q., Abidi P., Afaq F., Schiffmann D., Mossman B.T., Kamp D.W., Athar M. Glutathione redox system in oxidative lung injury. Crit. Rev. Toxicol. 1999, 29:543-568.
223. Adler V., Yin Z., Tew K.D., Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111.
224. Spiteri M.A., Biancoo A., Strange R.C., Fryer A.A. Polymorphisms at the glutathione S-transferase, GSTP1 locus: A novel mechanism for susceptibility and development of atopic airway inflammation. Allergy 2000, 55(Suppl 66):15-20.
225. Fujii J., Suzuki K., Taniguchi N. Physiological significance of superoxide dismutase isozymes. Nippon Rinsho. 1995, 53:1227-1231.
226. Macmillan-Crow L.A., Cruthirds D.L. Invited review: Manganese superoxide dismutase in disease. Free Radic. Res. 2001, 34:325-336.
227. Maier C.M., Chan P.H. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 2002, 8:323-334.
228. Laloraya M., Kumar G.P., Laloraya M.M. Histochemical study of superoxide dismutase in the ovary of the rat during the oestrous cycle. J Reprod. Fertil. 1989, 86:583-587.
229. Sato E.F., Kobuchi H., Edashige K., Takahashi M., Yoshioka T., Utsumi K., Inoue M. Dynamic aspects of ovarian superoxide dismutase isozymes during the ovulatory process in the rat. FEBS Lett. 1992, 303:121-125.
230. Sasaki J., Sato E.F., Nomura T., Mori H., Watanabe S., Kanda S., Watanabe H., Utsumi K., Inoue M. Detection of manganese superoxide dismutase mRNA in the theca interna cells of rat ovary during the ovulatory process by in situ hybridization. Histochemistry 1994, 102:173-176.
231. Nomura T., Sasaki J., Mori H., Sato E.F., Watanabe S., Kanda S., Matsuura J., Watanabe H., Inoue M. Expression of manganese superoxide dismutase mRNA in reproductive organs during the ovulatory process and the estrous cycle of the rat. Histochem. Cell Biol. 1996, 105:1-6.
232. Penning T.M., Pawlowski J.E., Schlegel B.P., Jez J.M., Lin H.K., Hoog S.S., Bennett M.J., Lewis M. Mammalian 3α-hydroxysteroid dehydrogenases. Steroids 1996, 61:508-523.
233. Ma H., Penning T.M. Conversion of mammalian 3α-hydroxysteroid dehydrogenase to 20α-hydroxysteroid dehydrogenase using loop chimeras: Changing specificity from androgens to progestins. Proc. Natl. Acad. Sci. USA 1999, 96:11161-11166.
234. Espey L.L., Yoshioka S., Ujioka T., Fujii S., Richards J.S. 3α-Hydroxysteroid dehydrogenase messenger RNA transcription in the immature rat ovary in response to an ovulatory dose of gonadotropin. Biol. Reprod. 2001, 65:72-78.
235. Forrest G.L., Gonzalez B. Carbonyl reductase. Chem. Biol. Interact. 2000, 129:21-40.
236. Espey L.L., Yoshioka S., Russell D., Ujioka T., Vladu B., Skelsey M., Fujii S., Okamura H., Richards J.S. Characterization of ovarian carbonyl reductase gene expression during ovulation in the gonadotropin-primed immature rat. Biol. Reprod. 2000, 62:390-397.
237. Dalton T.P., Puga A., Shertzer H.G. Induction of cellular oxidative stress by aryl hydrocarbon receptor activation. Chem. Biol. Interact. 2002, 141:77-95.
238. Balint E.E., Vousden K.H. Activation and activities of the p53 tumour suppressor protein. Br. J. Cancer 2001, 85:1813-1823.
239. Matuoka K., Chen K.Y. Transcriptional regulation of cellular ageing by the CCAAT box-binding factor CBF/NF-Y. Ageing Res. Rev. 2002, 1:639-651.
240. Barouki R., Morel Y. Repression of cytochrome P450 1A1 gene expression by oxidative stress: Mechanisms and biological implications. Biochem. Pharmacol. 2001, 61:511-516.
241. Bouma-ter Steege J.C., Mayo K.H., Griffioen A.W. Angiostatic proteins and peptides. Crit. Rev. Eukaryot. Gene Expr. 2001, 11:319-334.
242. Distler O., Neidhart M., Gay R.E., Gay S. The molecular control of angiogenesis. Int. Rev. Immunol. 2002, 21:33-49.
243. Nguyen M., Arkell J., Jackson C.J. Human endothelial gelatinases and angiogenesis. Int. J. Biochem. Cell. Biol. 2001, 33:960-970.
244. Martin J. Learning from vascular remodelling. Clin. Exp. Allergy 2000, 30(Suppl 1):33-36.
245. Pages G., Milanini J., Richard D.E., Berra E., Gothie E., Vinals F., Pouyssegur J. Signaling angiogenesis viap42/p44 MAP kinase cascade. Ann. N. Y. Acad. Sci. 2000, 902:187-200.
246. Masferrer J. Approach to angiogenesis inhibition based on cyclooxygenase-2. Cancer J. 2001, 7(Suppl 3):S144-S150.
247. Dermond O., Ruegg C. Inhibition of tumor angiogenesis by nonsteroidal anti-inflammatory drugs: Emerging mechanisms and therapeutic perspectives. Drug Resist. Updat. 2001, 4:314-321.
248. Lema M.J. Emerging options with coxib therapy. Cleve. Clin. J. Med. 2002, 69(Suppl 1):S176-S184.
249. Wilson K.T. Angiogenic markers, neovascularization, and malignant deformation of Barrett's esophagus. Dis. Esophagus 2002, 15:16-21.
250. Sang Q.X. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 1998, 8:171-177.
251. Jackson C., Nguyen M., Arkell J., Sambrook P. Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis-targetting gelatinase A activation. Inflamm. Res. 2001, 50:183-186.
252. Collen A., Hanemaaijer R., Lupu F., Quax P.H., Van Lent N., Grimbergen J., Peters E., Koolwijk P., Van Hinsbergh V.W. Membrane-type matrix metalloproteinase mediated angiogenesis in a fibrin-collagen matrix. Blood 2003, 101:1810-1817.
253. Mannello F., Gazzanelli G. Tissue inhibitors of metalloproteinases and programmed cell death: Conundrums, controversies, and potential implications. Apoptosis 2001, 6:479-482.
254. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1104-1117.
255. Wojtukiewicz M.Z., Sierko E., Klement P., Rak J. The hemostatic system and angiogenesis in malignancy. Neoplasia 2001, 3:371-384.
256. Klafter R., Arbiser J.L. Regulation of angiogenesis and tumorigenesis by signal transduction cascades: Lessons from benign and malignant endothelial tumors. J. Investig. Dermatol. Symp. Proc. 2000, 5:79-82.
257. Xu H., Raafat el-Gewely M. P53-responsive genes and the potential for cancer diagnostics and therapeutics development. Biotechnol. Annu. Rev. 2001, 7:131-164.
258. Jozzo R.V., San Antonio J.D. Heparan sulfate proteoglycans: Heavy hitters in the angiogenesis arena. J. Clin. Invest. 2001, 108:349-355.
259. Nishihira J. Macrophage migration inhibitory factor (MIF): Its essential role in the immune system and cell growth. J. Interferon Cytokine Res. 2000, 20:751-762.
260. Espey L.L. Ovarian contractility and its relationship to ovulation: A review. Biol. Reprod. 1978, 19:540-555.
261. Bjersing L., Cajander S. Ovulation and the mechanism of follicle rupture. III. Transmission electron microscopy of rabbit germinal epithelium prior to induced ovulation. Cell Tissue Res. 1974, 149:313-327.
262. Murdoch W.J. Proteolytic and cellular death mechanisms in ovulatory ovarian rupture. Biol. Signals Recept. 2000, 9:102-114.
263. Murdoch W.J., McDonnel A.C. Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 2002, 123.